Viridian Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 05/15/2026 | 15.38 M | $300.82 M | 6.92% | 18.14% |
| BLACKROCK, INC. | 05/13/2026 | 7.83 M | $153.18 M | 21.76% | 9.23% |
| BELLEVUE GROUP AG | 05/15/2026 | 6.73 M | $131.56 M | 54.32% | 7.93% |
| STATE STREET CORP | 05/15/2026 | 4.67 M | $91.40 M | 34.80% | 5.51% |
| 05/15/2026 | 4.17 M | $81.51 M | 100.00% | 4.91% | |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 05/15/2026 | 3.91 M | $76.57 M | 0.00% | 4.62% |
| VR ADVISER, LLC | 05/15/2026 | 3.88 M | $75.95 M | 0.00% | 4.58% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 3.21 M | $62.71 M | -6.79% | 3.78% |
| PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2026 | 3.15 M | $61.59 M | 118.20% | 3.71% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 3.08 M | $60.22 M | 56.16% | 3.63% |
| KYNAM CAPITAL MANAGEMENT, LP | 05/15/2026 | 2.34 M | $45.80 M | 59.24% | 2.76% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 2.33 M | $45.65 M | 17.12% | 2.75% |
| CITADEL ADVISORS LLC | 05/15/2026 | 2.32 M | $45.34 M | 241.07% | 2.73% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 2.32 M | $45.30 M | 359.64% | 2.73% |
| NOVO HOLDINGS A/S | 05/15/2026 | 2.00 M | $39.12 M | -15.97% | 2.36% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 1.97 M | $38.57 M | 0.00% | 2.33% |
| TANG CAPITAL MANAGEMENT LLC | 05/15/2026 | 1.79 M | $35.06 M | 0.00% | 2.11% |
| FISHER ASSET MANAGEMENT, LLC | 05/05/2026 | 1.77 M | $34.59 M | -0.67% | 2.09% |
| 05/08/2026 | 1.64 M | $32.11 M | 100.00% | 1.94% | |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 1.59 M | $31.14 M | 25.94% | 1.88% |
| AVORO CAPITAL ADVISORS LLC | 05/15/2026 | 1.50 M | $29.34 M | 0.00% | 1.77% |
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 1.39 M | $27.27 M | -44.79% | 1.64% |
| ALLIANCEBERNSTEIN L.P. | 05/15/2026 | 1.39 M | $43.32 M | -1.56% | 1.64% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 1.26 M | $24.70 M | 26.16% | 1.49% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 1.17 M | $22.90 M | -61.52% | 1.38% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 1.16 M | $22.76 M | 17.52% | 1.37% |
| JPMORGAN CHASE & CO | 05/13/2026 | 1.06 M | $19.64 M | 4.91% | 1.25% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 1.03 M | $20.19 M | 115.17% | 1.22% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 970.02 K | $18.97 M | 22.78% | 1.14% |
| LOOMIS SAYLES & CO L P | 05/14/2026 | 927.72 K | $18.15 M | -37.36% | 1.09% |
| FIRST TURN MANAGEMENT, LLC | 05/15/2026 | 911.34 K | $17.83 M | 31.98% | 1.07% |
| RICE HALL JAMES & ASSOCIATES, LLC | 05/15/2026 | 898.61 K | $17.58 M | 1.59% | 1.06% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/13/2026 | 888.30 K | $17.38 M | 537.41% | 1.05% |
| MORGAN STANLEY | 05/15/2026 | 870.16 K | $17.02 M | -49.94% | 1.03% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 727.94 K | $14.24 M | -2.81% | 0.86% |
| EVERSEPT PARTNERS, LP | 05/15/2026 | 713.27 K | $13.95 M | -59.98% | 0.84% |
| CANDRIAM S.C.A. | 04/30/2026 | 711.74 K | $13.92 M | -9.34% | 0.84% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 05/14/2026 | 708.53 K | $13.86 M | 1,510.84% | 0.84% |
| WOODLINE PARTNERS LP | 05/15/2026 | 700.93 K | $13.71 M | -37.19% | 0.83% |
| NORTHERN TRUST CORP | 05/14/2026 | 697.00 K | $13.63 M | 4.28% | 0.82% |
| FEDERATED HERMES, INC. | 05/11/2026 | 668.97 K | $13.09 M | 60.67% | 0.79% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 649.87 K | $12.71 M | 100.00% | 0.77% |
| NUVEEN, LLC | 04/30/2026 | 604.91 K | $11.83 M | -18.51% | 0.71% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 591.23 K | $11.56 M | 100.00% | 0.70% |
| ALGERT GLOBAL LLC | 05/14/2026 | 564.00 K | $11.03 M | 32.69% | 0.67% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2026 | 557.94 K | $10.91 M | -29.20% | 0.66% |
| 05/15/2026 | 534.93 K | $10.46 M | -37.70% | 0.63% | |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 529.76 K | $10.35 M | -4.65% | 0.62% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 05/14/2026 | 330.39 K | $6.46 M | 256.42% | 0.39% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 322.84 K | $6.31 M | 26.96% | 0.38% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Viridian Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 284 institutional investors and hedge funds held shares of Viridian Therapeutics Inc. The most heavily invested institutionals were:
FMR LLC: 15.38 M
BlackRock, Inc.: 7.83 M
Bellevue Group AG: 6.73 M
STATE STREET CORP: 4.67 M
Fairmount Funds Management LLC: 3.91 M
VR Adviser, LLC: 3.88 M
132.52% of Viridian Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 118.84 M shares in the last 24 months. This purchase volume represents approximately $3.52 B in transactions.